NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,239 filers reported holding NOVARTIS A G in Q1 2024. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $466,858 | +9.9% | 4,382 | -0.2% | 0.31% | +10.6% |
| Q1 2024 | $424,838 | -10.9% | 4,392 | -6.9% | 0.28% | -16.0% |
| Q4 2023 | $476,578 | -6.6% | 4,720 | -5.8% | 0.34% | -8.7% |
| Q3 2023 | $510,522 | +9.0% | 5,012 | +8.0% | 0.37% | +11.5% |
| Q2 2023 | $468,222 | +10.1% | 4,640 | +0.4% | 0.33% | +4.1% |
| Q1 2023 | $425,132 | +9.2% | 4,621 | +7.7% | 0.32% | +7.8% |
| Q4 2022 | $389,280 | +55.1% | 4,291 | +30.0% | 0.30% | +48.2% |
| Q3 2022 | $251,000 | +22.4% | 3,301 | +41.5% | 0.20% | +36.3% |
| Q1 2022 | $205,000 | -1.0% | 2,333 | -1.4% | 0.15% | +0.7% |
| Q4 2021 | $207,000 | +1.5% | 2,366 | -4.9% | 0.14% | -5.2% |
| Q3 2021 | $204,000 | -7.7% | 2,489 | +2.8% | 0.15% | -7.8% |
| Q2 2021 | $221,000 | +6.2% | 2,422 | -0.6% | 0.17% | -1.2% |
| Q1 2021 | $208,000 | -15.1% | 2,436 | -6.1% | 0.17% | -24.3% |
| Q4 2020 | $245,000 | – | 2,594 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |